Bullfrog AI gains on early findings from research deal with Lieber Institute
17/01/2024 15:35
** Shares of artificial intelligence-based drug development
firm Bullfrog AI BFRG.O rise 37.9% to $3.7 - on track for
biggest one-day pct gain in nearly six months
** Co announces early findings from analyzing brain
expression data through its AI-based bfLEAP platform, in
partnership with non-profit Lieber Institute for Brain
Development (LIBD)
** LIBD provided access to gene expression data from over
2,800 brain samples on various brain disorders including
schizophrenia and bipolar disorders
** Co says the findings from data could help identify
distinct differences and similarities across various brain
disorders, which will help identify and develop personalized
treatment strategies
** As of last close, stock has fallen 44.5% since Nasdaq
debut in Feb 2023
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))